2016 Biotech Charity Contest Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : 2016 Biotech Charity Contest

XBI 111.91

+0.9%

Oct 30 4:00 PM EDT

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: jbogd

1/2/2017 4:22:46 PM

Read Replies (3) of 311

I look forward to another year. $250 to the winning charity.

TBPH		20
ARIA		20
ALXN		10
IPH.PA		10
VRX		10
EDIT		10
EXEL		10
IONS		5
ARQL		5

We should clarify how the buyouts with a CVR's are accounted for as it was instrumental in the 2016 contest.

Allergan purchased Tobira for $28.35 in cash and a possible additional $49.84 in future CVRs. Upon the closing date Tobira was trading for $40.92 so how should this be handled.

Should of the $28.35 be re-deployed back into the other stocks and $12.57 be retained in the Tobira line or should have the whole $40.92 be re-deployed and the holder foregoes the CVR?

Had the first example been used, SteveL would have still won by around $75 by my accounting.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next